When Barry and Wyatt Dusome first took on the Canadian Intellectual Property Office (CIPO) without legal representation, they beat long odds. We wrote about that rare victory in the area of patent eligibility. In 2025, the Federal Court found that the Commissioner of Patents had erred by failing to apply proper purposive construction to their...Read More
On July 17, 2026, the Supreme Court of Canada released its long-awaited decision in Pharmascience Inc. v. Janssen Inc., 2026 SCC 26. In a significant ruling for pharmaceutical patentees and generic manufacturers, the Court dismissed the appeal and affirmed both the continued existence of the methods-of-medical-treatment doctrine and the validity of Janssen’s patent covering dosing...Read More
Imagine you are in court alone without a lawyer, making complex arguments on behalf of yourself and your co-inventor, as to why the patent office made a mistake in rejecting your patent application. Specifically that your invention is patent eligible. Everyone opposing you is a paid professional. It is not hard to see that the...Read More
